{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:14Z","timestamp":1792382894953,"version":"4.4.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1558,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International Supplements"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1038\/kisup.2011.28","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T17:37:00Z","timestamp":1314812220000},"page":"122-129","source":"Crossref","is-referenced-by-count":39,"title":["Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation"],"prefix":"10.1016","volume":"1","author":[{"given":"Jordi","family":"Bover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/kisup.2011.28_bb0010","series-title":"The Kidney","first-page":"2103","article-title":"Renal osteodystrophies","author":"Llach","year":"2000"},{"key":"10.1038\/kisup.2011.28_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ki.1994.129","article-title":"Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat","volume":"45","author":"Bover","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/039139880903200203","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"32","author":"Cozzolino","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1038\/kisup.2011.28_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0030","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/ndt\/gfq313","article-title":"The expanding spectrum of biological actions of vitamin D","volume":"25","author":"Rojas-Rivera","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000209246","article-title":"Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease","volume":"27","author":"Cozzolino","year":"2009","journal-title":"Blood Purif"},{"key":"10.1038\/kisup.2011.28_bb0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2010.260","article-title":"Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients","volume":"78","author":"Krajisnik","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2215\/CJN.06661208","article-title":"Bone-vascular axis in chronic kidney disease: a reality?","volume":"4","author":"London","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0050","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/kisup.2011.28_bb0055","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/kisup.2011.28_bb0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/kisup.2011.29","article-title":"Fibroblast growth factor 23 and Klotho in chronic kidney disease","volume":"1","author":"Vervloet","year":"2011","journal-title":"Kidney inter., Suppl."},{"key":"10.1038\/kisup.2011.28_bb0065","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0070","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD\u2013MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/kisup.2011.28_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","article-title":"Adynamic bone disease: clinical and therapeutic implications","volume":"18","author":"Frazao","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/kisup.2011.28_bb0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"key":"10.1038\/kisup.2011.28_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1038\/kisup.2011.28_bb0110","first-page":"135","article-title":"Adynamic bone disease-bone and beyond","volume":"3","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"key":"10.1038\/kisup.2011.28_bb0115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1\u201384 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-67-5-929","article-title":"Low dose calcitriol versus placebo in patients with predialysis chronic renal failure","volume":"67","author":"Nordal","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"10.1038\/kisup.2011.28_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1038\/kisup.2011.28_bb0130","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1038\/kisup.2011.28_bb0145","first-page":"21","article-title":"Low turn-over bone disease in patients with chronic renal disease","volume":"60","author":"Spasovski","year":"2007","journal-title":"Med Pregl"},{"key":"10.1038\/kisup.2011.28_bb0150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0155","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","article-title":"The link between bone and coronary calcifications in CKD-5 patients on haemodialysis","volume":"26","author":"Asci","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0160","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.ajkd.2006.05.028","article-title":"Variant of adynamic bone disease in hemodialysis patients: fact or fiction?","volume":"48","author":"Rocha","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1755.1998.00080.x","article-title":"Hypokinetic azotemic osteodystrophy","volume":"54","author":"Cannata-Andia","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","article-title":"The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia","volume":"46","author":"Bover","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S8756-3282(99)00169-6","article-title":"Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus","volume":"25","author":"Bover","year":"1999","journal-title":"Bone"},{"key":"10.1038\/kisup.2011.28_bb0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1038\/kisup.2011.28_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2006.01663.x","article-title":"Function and effect of bone morphogenetic protein-7 in kidney bone and the bone\u2013vascular links in chronic kidney disease","volume":"36","author":"Mathew","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1038\/kisup.2011.28_bb0190","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ki.1991.118","article-title":"Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma","volume":"39","author":"Andress","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0195","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7\u201384)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/kisup.2011.28_bb0200","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0215","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0220","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0225","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca x PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0230","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jsbmb.2004.03.026","article-title":"Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice","volume":"90","author":"Dardenne","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/kisup.2011.28_bb0240","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","article-title":"Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis","volume":"279","author":"Panda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/kisup.2011.28_bb0245","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"van Driel","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1038\/kisup.2011.28_bb0250","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"10.1038\/kisup.2011.28_bb0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S8756-3282(03)00202-3","article-title":"Anabolic and catabolic bone effects of human parathyroid hormone (1\u201334) are predicted by duration of hormone exposure","volume":"33","author":"Frolik","year":"2003","journal-title":"Bone"},{"key":"10.1038\/kisup.2011.28_bb0260","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/endo-127-2-942","article-title":"Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo","volume":"127","author":"Reinhardt","year":"1990","journal-title":"Endocrinology"},{"key":"10.1038\/kisup.2011.28_bb0265","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1681\/ASN.2009050531","article-title":"Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis","volume":"21","author":"Nguyen-Yamamoto","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0270","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bone.2009.07.013","article-title":"Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol","volume":"45","author":"Shiizaki","year":"2009","journal-title":"Bone"},{"key":"10.1038\/kisup.2011.28_bb0275","doi-asserted-by":"crossref","first-page":"e8670","DOI":"10.1371\/journal.pone.0008670","article-title":"Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes","volume":"5","author":"Silvagno","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/kisup.2011.28_bb0280","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2005.07.007","article-title":"Differential effects of Vitamin D analogs on bone formation and resorption","volume":"98","author":"Nakane","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/kisup.2011.28_bb0285","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1\u201384)\/large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0290","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1046\/j.1523-1755.2003.00029.x","article-title":"Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia","volume":"63","author":"Slatopolsky","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0295","first-page":"637","article-title":"Unawareness of the K\/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey","volume":"28","author":"Bover","year":"2008","journal-title":"Nefrologia"},{"key":"10.1038\/kisup.2011.28_bb0300","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2014achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0310","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2215\/CJN.03461006","article-title":"Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1\u201384)\/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease","volume":"2","author":"Monier-Faugere","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0315","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0320","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00041552-200207000-00011","article-title":"Novel mechanisms in accelerated vascular calcification in renal disease patients","volume":"11","author":"Demer","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/kisup.2011.28_bb0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MNH.0b013e32833a3d67","article-title":"The bone\u2013vascular axis in chronic kidney disease","volume":"19","author":"Demer","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/kisup.2011.28_bb0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0340","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0345","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0350","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0355","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0360","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1523-1755.2004.66095.x","article-title":"Vascular calcification in ESRD: Another cloud appears in the perfect storm\u2014but highlights a silver lining?","volume":"66","author":"Towler","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0365","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/kisup.2011.27","article-title":"Ten years of progress in our understanding of uremic vascular calcification and disease: a decade summarized in 20 steps","volume":"1","author":"Brandenburg","year":"2011","journal-title":"Kidney inter., Suppl."},{"key":"10.1038\/kisup.2011.28_bb0370","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0375","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0380","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: the role of \u2018suppressed\u2019 parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0385","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1359\/jbmr.090735","article-title":"Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment","volume":"25","author":"Tomiyama","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1038\/kisup.2011.28_bb0390","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1523-1755.2005.00239.x","article-title":"Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors","volume":"67","author":"Barreto","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0395","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1053\/j.ajkd.2008.06.024","article-title":"Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study","volume":"52","author":"Barreto","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0400","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2215\/CJN.01870408","article-title":"Low bone volume\u2014a risk factor for coronary calcifications in hemodialysis patients","volume":"4","author":"Adragao","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0405","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/089686080802800621","article-title":"Bone mineral density, vascular calcifications, and arterial stiffness in peritoneal dialysis patients","volume":"28","author":"Adragao","year":"2008","journal-title":"Perit Dial Int"},{"key":"10.1038\/kisup.2011.28_bb0410","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00198-009-0988-9","article-title":"Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients","volume":"21","author":"Adragao","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1038\/kisup.2011.28_bb0415","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/JBMR.050711","article-title":"Relationship between osteoporosis and cardiovascular disease in postmenopausal women","volume":"20","author":"Tanko","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1038\/kisup.2011.28_bb0420","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1523-1755.2002.kid573.x","article-title":"Differential effects of 19-nor-1,25-(OH)2D2 and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats","volume":"62","author":"Slatopolsky","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0425","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1053\/ajkd.2002.36899","article-title":"Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients","volume":"40","author":"Coyne","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0430","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1111\/j.1753-4887.2008.00105.x","article-title":"Evolution of our understanding of vitamin D","volume":"66","author":"DeLuca","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1038\/kisup.2011.28_bb0435","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","article-title":"A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia","volume":"26","author":"Slatopolsky","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0440","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gfg296","article-title":"In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3","volume":"18","author":"Hirata","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0445","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.ki.5002406","article-title":"Differential effects of vitamin D receptor activators on vascular calcification in uremic rats","volume":"72","author":"Mizobuchi","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0450","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Cardus","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1038\/kisup.2011.28_bb0455","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.ki.5002675","article-title":"The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats","volume":"73","author":"Lopez","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0460","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000223801","article-title":"Importance of vitamin D receptor activation in clinical practice","volume":"163","author":"Cozzolino","year":"2009","journal-title":"Contrib Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0465","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/157016108783955310","article-title":"Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol","volume":"6","author":"Cozzolino","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"issue":"Suppl 1","key":"10.1038\/kisup.2011.28_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1755-6686.2009.00049.x","article-title":"Update on the treatment of chronic kidney disease\u2013mineral and bone disorder","volume":"35","author":"Bover","year":"2009","journal-title":"J Ren Care"},{"key":"10.1038\/kisup.2011.28_bb0475","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/039139880903200201","article-title":"The link between bone and cardiovascular disease in CKD: new insights into pathogenesis and treatment","volume":"32","author":"Cozzolino","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1038\/kisup.2011.28_bb0480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/kisup.2011.26","article-title":"Vitamin D deficiency and heart disease","volume":"1","author":"Pilz","year":"2011","journal-title":"Kidney inter., Suppl."},{"key":"10.1038\/kisup.2011.28_bb0485","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2215\/CJN.01220308","article-title":"Vitamin D and osteogenic differentiation in the artery wall","volume":"3","author":"Hsu","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0490","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5414\/CNP71593","article-title":"Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the \u2018U\u2019","volume":"71","author":"Cozzolino","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0495","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ki.2008.35","article-title":"Vitamin D receptor activation and survival in chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0500","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/ajkd.2001.28582","article-title":"Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients","volume":"38","author":"Marco","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/kisup.2011.28_bb0505","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","article-title":"Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population","volume":"19","author":"Shoji","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0510","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0515","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0520","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/kisup.2011.28_bb0525","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/kisup.2011.28_bb0530","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/ndt\/gfn592","article-title":"The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study","volume":"24","author":"Tentori","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/kisup.2011.28_bb0535","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000209250","article-title":"Dietary and pharmacological control of calcium and phosphate metabolism in dialysis patients","volume":"27","author":"Bover","year":"2009","journal-title":"Blood Purif"},{"key":"10.1038\/kisup.2011.28_bb0540","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2010.113","article-title":"Use of vitamin D in chronic kidney disease patients","volume":"78","author":"Gal-Moscovici","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/kisup.2011.28_bb0545","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"}],"container-title":["Kidney International Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171615310273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171615310273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T11:58:42Z","timestamp":1638446322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2157171615310273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S2157171615310273"],"URL":"https:\/\/doi.org\/10.1038\/kisup.2011.28","relation":{},"ISSN":["2157-1716"],"issn-type":[{"value":"2157-1716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}